loading
前日終値:
$2.37
開ける:
$2.34
24時間の取引高:
194.15K
Relative Volume:
0.61
時価総額:
$2.37M
収益:
-
当期純損益:
$-4.21M
株価収益率:
-41.97
EPS:
-0.0548
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.29%
1か月 パフォーマンス:
-60.00%
6か月 パフォーマンス:
-97.95%
1年 パフォーマンス:
-99.89%
1日の値動き範囲:
Value
$2.29
$2.4324
1週間の範囲:
Value
$2.23
$2.5893
52週間の値動き範囲:
Value
$2.23
$2,565.00

Conduit Pharmaceuticals Inc Stock (CDT) Company Profile

Name
名前
Conduit Pharmaceuticals Inc
Name
セクター
Healthcare (1174)
Name
電話
(646) 491 9132
Name
住所
4851 TAMIAMI TRAIL NORTH, NAPLES
Name
職員
6
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
CDT's Discussions on Twitter

CDT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CDT
Conduit Pharmaceuticals Inc
2.30 2.37M 0 -4.21M 0 -0.0548
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
440.87 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
509.72 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
309.70 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.15 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
247.08 28.51B 3.81B -644.79M -669.77M -6.24

Conduit Pharmaceuticals Inc (CDT) 最新ニュース

pulisher
Jun 07, 2025

Conduit Pharmaceuticals (NASDAQ:CDT) Stock Price Down 0.4% – What’s Next? - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10 - MENAFN.com

Jun 05, 2025
pulisher
Jun 04, 2025

Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10 By Stocktwits - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

Conduit Pharmaceuticals enters joint development agreement with Manoira - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Conduit Pharma Expands Drug Pipeline to $15B Animal Health Market Through Zero-Cost Development Deal - Stock Titan

Jun 04, 2025
pulisher
Jun 03, 2025

Conduit Pharmaceuticals Sets 2025 Annual Meeting Date - TipRanks

Jun 03, 2025
pulisher
May 31, 2025

CDT stock plunges to 52-week low, hitting $3.21 amid steep decline By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

CDT stock plunges to 52-week low, hitting $3.21 amid steep decline - Investing.com India

May 30, 2025
pulisher
May 27, 2025

Conduit Pharmaceuticals regains Nasdaq compliance - MSN

May 27, 2025
pulisher
May 23, 2025

Conduit Pharmaceuticals receives approval for Nasdaq listing - MSN

May 23, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals approved to transfer listing to Nasdaq Capital Market - TipRanks

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals moves to Nasdaq Capital Market By Investing.com - Investing.com India

May 22, 2025
pulisher
May 22, 2025

Conduit Pharma Gains Nasdaq Capital Market Approval, Transfer Effective May 23 - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals moves to Nasdaq Capital Market - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Biotech Rising Star Conduit Pharmaceuticals Gets Green Light for Nasdaq Capital Market Transfer - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals meets Nasdaq listing standards By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals meets Nasdaq listing standards - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Regains Compliance With Nasdaq's Bid Price, Equity Requirements - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Inc. Regains Compliance with Nasdaq Listing Requirements - Nasdaq

May 21, 2025
pulisher
May 19, 2025

Upcoming Stock Splits This Week (May 19 to May 23) – Stay Invested - The Globe and Mail

May 19, 2025
pulisher
May 17, 2025

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic - MSN

May 17, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals approves reverse stock split By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic By Stocktwits - Investing.com India

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Announces Reverse Stock Split - TipRanks

May 16, 2025
pulisher
May 16, 2025

Barclays PLC Buys 54,523 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) - Defense World

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - The Manila Times

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals approves reverse stock split - Investing.com

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Inc. Announces 1-for-15 Reverse Stock Split Approval - Nasdaq

May 16, 2025
pulisher
May 15, 2025

CONDUIT PHARMACEUTICALS INC. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 15, 2025
pulisher
May 09, 2025

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - The Manila Times

May 09, 2025
pulisher
May 09, 2025

Conduit Pharmaceuticals Secures Korean Patent for AZD1656, Advancing Global Development Strategy for Autoimmune Disorders - Nasdaq

May 09, 2025
pulisher
May 08, 2025

Conduit Pharmaceuticals Files New Patent For AZD5904 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

In 2025, Will Conduit Pharmaceuticals Inc (NASDAQ: CDT) Be Bullish Or Bearish? - Stocksregister

May 08, 2025
pulisher
May 08, 2025

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset - The Manila Times

May 08, 2025
pulisher
May 06, 2025

Conduit Pharmaceuticals Approves Reverse Stock Split Amendments - TipRanks

May 06, 2025
pulisher
May 06, 2025

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Shares Acquired by Geode Capital Management LLC - Defense World

May 06, 2025

Conduit Pharmaceuticals Inc (CDT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Conduit Pharmaceuticals Inc (CDT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Nirland Ltd
10% Owner
Oct 04 '24
Sale
0.10
1,368,991
140,458
7,031,009
Nirland Ltd
10% Owner
Oct 07 '24
Sale
0.10
939,009
96,530
6,092,000
Nirland Ltd
10% Owner
Oct 01 '24
Sale
0.11
1,250,000
141,375
10,233,177
Nirland Ltd
10% Owner
Sep 30 '24
Sale
0.12
1,016,823
122,019
11,483,177
Nirland Ltd
10% Owner
Oct 02 '24
Sale
0.10
333,177
34,251
9,900,000
Regan Andrew
Director
Jul 16 '24
Sale
0.32
10,244,392
3,246,448
1,691,727
Regan Andrew
Director
Jul 17 '24
Sale
0.26
1,514,100
391,092
177,627
Regan Andrew
Director
Jul 12 '24
Sale
0.25
1,389,820
343,425
12,941,319
Regan Andrew
Director
Jul 11 '24
Sale
0.29
882,952
260,253
14,331,139
Regan Andrew
Director
Jul 15 '24
Sale
0.25
1,005,200
248,385
11,936,119
$21.16
price down icon 1.86%
$34.86
price down icon 0.14%
$20.56
price up icon 1.98%
$102.68
price up icon 3.24%
$106.53
price up icon 2.04%
biotechnology ONC
$247.08
price down icon 2.25%
大文字化:     |  ボリューム (24 時間):